Skip to main content
OpenTrials
Completed

NCT Number: NCT02310503

Spanish Registry of Mohs Surgery

REGESMOHS (Registro Español de cirugía de Mohs) aims at describing effectiveness of Mohs surgery, and patient, tumor and technique factors related to adverse events and tumor recurrence.

REGESMOHS is a prospective cohort, including all patients considered for Mohs surgery in participating centers. All consecutive patients are included. The only exclusion criteria are being under 18-years-old or legally incompetent. Pre-planned follow-up is as required by common clinical practice, but at least once a year for the study period.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Skin Neoplasms Carcinoma Carcinoma, Basal Cell Carcinoma, Squamous Cell Dermatofibrosarcoma Fibrosarcoma Histiocytoma Histiocytoma, Malignant Fibrous Melanoma Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Adnexal and Skin Appendage Neoplasms, Basal Cell Neoplasms, Connective Tissue Neoplasms, Connective and Soft Tissue Neoplasms, Fibrous Tissue Neoplasms, Germ Cell and Embryonal Neoplasms, Glandular and Epithelial Neoplasms, Nerve Tissue Neoplasms, Squamous Cell Neuroectodermal Tumors Neuroendocrine Tumors Nevi and Melanomas Sarcoma Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Hospital Universitario de Cruces, Barakaldo, Spain

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All consecutive patients considered for Mohs surgery

Exclusion criteria

  • Under 18 years-old
  • Legally incompetent

Treatment and study plan

Mohs surgery

Procedure

A surgical technique used primarily in the treatment of skin neoplasms, especially basal cell or squamous cell carcinoma of the skin. This procedure is a microscopically controlled excision of cutaneous tumors either after fixation in vivo or after freezing the tissue. Serial examinations of fresh tissue specimens are most frequently done.

Primary outcomes

  1. Tumor recurrence

    Time frame: 6 years

Secondary outcomes

  1. Short term outcomes

    Time frame: 1 month

    Bleeding, infection, abnormal scar, necrosis

  2. Use of resources

    Time frame: During surgery

    Need for admission, type of anesthesia, number of surgical steps, participating doctors,time in surgery room.

  3. Impairments of body function and structure

    Time frame: 6 years

    presence of: abnormal scar, ectropion, nostril alteration, oral sphincter incompetence,other

Sponsors and collaborators

Lead sponsor

Fundación Academia Española de Dermatología

Other

Collaborators

  • Roche Pharma AG

Registry information

Official study title

Spanish Registry of Mohs Surgery [Registro Español de Cirugía de Mohs]

Acronym: REGESMOHS

Important dates

Study start
2013
Primary completion
2020
Study completion
2020
First posted
Dec 8, 2014
Registry last updated
May 5, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.